you've no other choice of being patient when dealing with a public service process.....a good day for them is payday,,,,,and a day when decisions are avoided,,,i think mesoblast products are seen as a game changer in medicine,,,and needs a higher level of decision making...
Si's FDA experience allows him to be focused yet relaxed with the process.....my thoughts anyway
Ann: DSMB Analysis Recommends to Continue P3 COVID-19 ARDS Trial, page-390
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.15 |
Change
0.045(4.07%) |
Mkt cap ! $1.313B | |||
| Open | High | Low | Value | Volume |
| $1.08 | $1.16 | $1.08 | $4.681M | 4.170M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 99680 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.16 | 31000 | 2 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |